MedTrace Logo

Molecular Analysis of IgE Antibodies in Walnut Allergic Patients

NCT02295267 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 61

Last updated 2017-05-11

No results posted yet for this study

Summary

Accurate diagnosis of food allergy depends on the identification of the causative allergenic molecule(s). The proposed study intends to investigate and compare the pattern of IgE antibody sensitisation in walnut allergic subjects from three different regions of Europe (south (SEU) and central/north (C/NEU), to evaluate the diagnostic utility of a panel of novel allergen reagents.

Conditions

Interventions

OTHER

walnut allergy provocation

double blind placebo controlled food challenge

Sponsors & Collaborators

  • Paul Ehrlich Institute Langen

    collaborator UNKNOWN

  • Hospital Clinic of Barcelona

    collaborator OTHER

  • St. Marien Hospital Bonn

    collaborator UNKNOWN

  • Thermo Fisher Scientific, Inc

    collaborator INDUSTRY

  • University of Zurich

    lead OTHER

Principal Investigators

  • Barbara Ballmer-Weber, PI · Allergy Unit, Department of Dermatology, University Zürich

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
DOUBLE
Model
SINGLE_GROUP

Eligibility

Min Age
1 Year
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-12-31
Primary Completion
2017-01-31
Completion
2017-03-31

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02295267 on ClinicalTrials.gov